Prognostic Value of CD133 and SOX2 in Advanced Cancer

BACKGROUND: The prognostic value of CD133 and SOX2 expression in advanced cancer remains unclear. This study was first conducted to investigate the association between CD133 or SOX2 positivity and clinical outcomes for advanced cancer patients. METHODS: Hazard ratios (HRs) with 95% confidence interv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Oncol
Main Authors: Han, Susu, Huang, Tao, Wu, Xing, Wang, Xiyu, Liu, Shanshan, Yang, Wei, Shi, Qi, Li, Hongjia, Hou, Fenggang
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6332999/
https://ncbi.nlm.nih.gov/pubmed/30693028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3905817
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados